Literature DB >> 7245088

Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide.

A Kistler.   

Abstract

The susceptible stages and the malformation pattern produced by excess retinoic acid were investigated in rat fetuses. Retinoic acid (120 mg/kg body weight, suspended in rape oil) was administered orally to pregnant females on one of the first 20 days of gestation. Fetuses were examined for external and, after visualization of the skeleton with alizarin red, for skeletal malformations on the 21st day of gestation. Retinoic acid was highly embryolethal when administered on days 9 and 10 of gestation (96.2 and 100% resorptions). The earliest teratogenic effect of retinoic acid was noted on the 9th day of gestation. Severe multiple defects were produced by retinoic acid administration on days 9 and 11 of gestation, but more specific malformations involving the axial skeleton, the fore- and hindlimbs, and cleft palate resulted from treatment on days 12-18 of gestation. Cycloheximide, and inhibitor of protein synthesis, reduced the incidence of limb defects induced by retinoic acid. This result indicates that the teratogenic effect of retinoic acid on limb morphogenesis may be dependent upon continuous protein synthesis and is compatible with the view that vitamin A may act like a hormone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7245088     DOI: 10.1002/tera.1420230106

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  12 in total

1.  Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670).

Authors:  A Kistler; H Hummler
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

2.  Suppression by the cyclohexanetrione Ro 31-0521 of retinoic acid-induced teratogenicity.

Authors:  A Kistler
Journal:  Experientia       Date:  1986-01-15

3.  Interactive effects of cadmium and retinoic acid on mouse limb bud development in vitro.

Authors:  T Shury; C G Rousseaux; J Keiner; M Politis
Journal:  Bull Environ Contam Toxicol       Date:  1994-10       Impact factor: 2.151

4.  Teratogenicity of arotinoids (retinoids) in vivo and in vitro.

Authors:  A Kistler; T Tsuchiya; M Tsuchiya; M Klaus
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

5.  Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene.

Authors:  H M Sucov; K K Murakami; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Characterization of a retinoic acid responsive element isolated by whole genome PCR.

Authors:  M P Costa-Giomi; M P Gaub; P Chambon; P Abarzúa
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis.

Authors:  Michelle L Baack; Chunlin Wang; Shanming Hu; Jeffrey L Segar; Andrew W Norris
Journal:  Reprod Toxicol       Date:  2014-04-08       Impact factor: 3.143

8.  Retinoids inhibit the differentiation of embryonic-mouse mesenchymal cells in vitro.

Authors:  B Zimmermann; D Tsambaos
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

9.  Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570.

Authors:  A Kistler; B Galli; W B Howard
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

10.  Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture.

Authors:  R Bechter; G D Terlouw; M Tsuchiya; T Tsuchiya; A Kistler
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.